Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
enoxaparin (lovenox) (1 trial)
resveratrol (1 trial)
vitis vinifera (1 trial)
Carcinoma (Phase 2)
Carcinoma, Small Cell (Phase 2)
Cardiovascular Diseases (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Trials (2 total)
Trial APIs (3 total)